The co-inactivation of LKB1 and KEAP1 cooperatively promotes metabolic reprogramming in KRAS-mutant tumor, and even in the presence of KEAP1 inactivation, LKB1 inactivation modulates NRF2 activity through increased ROS levels (104). Here, KEAP1 is linked to neoplasm.